Recombinant Salmonella typhimurium Secreted effector protein sptP (sptP), partial

What is SptP and what are its primary functions in Salmonella pathogenesis?

SptP (Salmonella protein tyrosine phosphatase) is a multifunctional virulence effector protein delivered into host cells by Salmonella typhimurium via specialized type III secretion systems (T3SS). It possesses two distinct functional domains: an N-terminal domain that mimics GTPase-activating proteins (GAP) and a C-terminal protein tyrosine phosphatase (PTPase) domain .

The GAP domain functions primarily during the early stages of infection by deactivating Rho GTPases Rac and Cdc42, thereby reversing cytoskeletal rearrangements that were initially induced by other Salmonella effectors (SopE/E2/SopB) to facilitate bacterial entry . This activity helps restore normal host cell architecture after Salmonella has successfully invaded the cell.

The PTPase domain, conversely, plays a significant role during later infection stages by targeting host proteins involved in intracellular replication, particularly the AAA+ ATPase valosin-containing protein (VCP/p97) . Through specific dephosphorylation of VCP, SptP enhances pathogen replication within Salmonella-containing vacuoles (SCVs) .

Research methodologies for studying SptP function typically involve generating chromosomal deletion mutants (ΔsptP) and complementation strains, followed by comparative analysis of cellular phenotypes including cytoskeletal changes, SCV maturation, and bacterial replication efficiency.

How does SptP persist within host cells during Salmonella infection?

Unlike many bacterial effector proteins that undergo rapid degradation after delivery, SptP demonstrates remarkable persistence within host cells. Research has demonstrated that SptP can remain detectable for at least 8 hours post-infection . This longevity is achieved through SptP's ability to avoid proteasome-dependent degradation mechanisms .

Tracking SptP's fate after bacterial internalization typically involves:

• Creating epitope-tagged versions (e.g., SptP-FLAG) for enhanced detection

• Time-course analysis using immunoblotting of infected cell lysates

• Subcellular fractionation to determine localization patterns

• Immunofluorescence microscopy to visualize association with specific cellular compartments

Studies using these approaches have revealed that persistent SptP is not freely distributed in the host cytoplasm but associates with cellular membranes, particularly those of the SCV . Approximately 15% ± 3% of intracellular bacteria show SptP accumulation around their containing vacuoles .

The methodological approach to investigating SptP persistence should include appropriate controls to verify fractionation efficiency, such as markers for plasma membranes (caveolin), nuclei (histone), bacteria (AcrB), internal membranes (calnexin), and cytoplasm (Hsp90) .

What experimental evidence demonstrates the importance of SptP in Salmonella's intracellular lifecycle?

The significance of SptP in Salmonella's intracellular lifecycle has been established through comparative analysis of wild-type, deletion mutant (ΔsptP), and complemented strains. Key experimental findings include:

• SCV Maturation: While SptP deletion did not alter LAMP1 (lysosomal-associated membrane protein 1) acquisition by SCVs, overexpression of SptP accelerated LAMP1 recruitment during the first 4 hours post-infection .

• Salmonella-induced Filament (Sif) Formation: At 6 hours post-infection, Sif formation was observed in 54.6% ± 1.1% of cells infected with wild-type Salmonella, but reduced to 26.4% ± 1.1% in cells infected with the ΔsptP mutant . Complementation with plasmid-encoded SptP restored Sif formation to wild-type levels.

• Intracellular Replication: Wild-type Salmonella demonstrated 14.3- ± 1.4-fold replication at 8 hours post-infection, while the ΔsptP mutant showed only 4.2- ± 2.6-fold replication . Complementation with plasmid-encoded SptP not only restored but enhanced replication to 35.2- ± 2.8-fold .

These findings demonstrate that SptP, particularly its PTPase activity, significantly promotes Salmonella intracellular replication and the formation of Sifs, which are characteristic membrane fusion events during the replicative phase of infection.

How can SptP be utilized as a delivery system for heterologous antigens?

SptP has emerged as a promising vehicle for delivering heterologous antigens into the cytoplasm of host cells, particularly for inducing antigen-specific cytotoxic T-lymphocyte (CTL) responses. This application leverages SptP's natural ability to be translocated into host cells via the Salmonella T3SS.

The methodology for utilizing SptP as an antigen delivery system typically involves:

• Fusion Protein Design: Creating genetic constructs that fuse protective epitopes or antigen fragments to SptP, ensuring the fusion preserves both translocation efficiency and antigen presentation.

• Recombinant Attenuated Salmonella Vectors: Incorporating the fusion constructs into attenuated Salmonella enterica strains (RASV) that maintain T3SS functionality but have reduced pathogenicity.

• Immunological Evaluation: Assessing CTL responses through ex vivo restimulation assays, epitope-specific tetramer staining, and in vivo challenge studies.

This approach has shown promising results in several experimental systems:

• When a major histocompatibility complex (MHC) class I epitope from lymphocytic choriomeningitis virus was fused to SptP and delivered via Salmonella, it induced strong and persistent virus-specific CTL responses in mice that provided protection against viral challenge .

• Similarly, fragments of the simian immunodeficiency virus (SIV) Gag protein fused to another Salmonella effector protein (SopE) induced virus-specific CD4+ and CD8+ T-cell responses in Rhesus macaques, though this was insufficient for protection against SIV challenge .

A key advantage of this approach is that it facilitates cytoplasmic delivery of antigens, promoting their processing through the MHC class I pathway for efficient CTL induction.

What is the relationship between SptP's phosphatase activity, VCP, and Salmonella intracellular replication?

SptP's C-terminal protein tyrosine phosphatase (PTPase) domain targets the host AAA+ ATPase valosin-containing protein (VCP/p97), a critical regulator of cellular membrane fusion and protein degradation processes. This relationship plays a fundamental role in promoting Salmonella intracellular replication.

Key experimental findings establish this relationship:

• SptP-VCP Interaction: SptP directly binds to and specifically dephosphorylates VCP, altering its functional properties within infected cells .

• VCP Localization: VCP is present in multiple cellular compartments, including those containing internalized bacteria. Approximately 12% ± 4% of intracellular bacteria show VCP localization around them .

• Effect on Sif Formation: VCP and its adaptors p47 and Ufd1 are necessary for generating Salmonella-induced filaments (Sifs) on SCVs, which are characteristic membrane fusion events during the replicative phase of infection .

• Impact on Bacterial Replication: SptP-mediated dephosphorylation of VCP enhances pathogen replication within SCVs .

The methodological approach to investigating this relationship typically involves:

• Cell fractionation to determine subcellular localization of VCP in infected cells

• Immunofluorescence microscopy to visualize VCP association with intracellular bacteria

• In vitro phosphatase assays to assess SptP's activity against VCP

• Genetic manipulation of VCP levels or phosphorylation state to assess effects on bacterial replication

This SptP-VCP interaction represents a sophisticated mechanism by which Salmonella regulates the biogenesis of its intracellular niche through targeted modification of host cellular machinery.

What experimental designs are most effective for studying SptP's dual functions?

Given SptP's dual functionality – the N-terminal GAP domain and C-terminal PTPase domain – effective experimental designs must distinguish between these activities while accounting for their potential interdependence. A comprehensive research approach should include:

• Domain-specific Mutational Analysis:

  • Creating point mutations that selectively inactivate either the GAP domain (e.g., R209A) or the PTPase domain (e.g., C481S) without affecting protein stability or translocation

  • Generating domain truncation mutants that express only the GAP or PTPase domain

• Temporal Analysis:

  • Time-course studies tracking different cellular responses (cytoskeletal changes, SCV maturation, Sif formation)

  • Inducible expression systems to control when specific SptP variants are expressed during infection

• Substrate Identification and Validation:

  • Substrate-trapping mutants that bind but do not release substrates

  • Phosphoproteomic analysis comparing wild-type and SptP-deficient infections

  • In vitro biochemical assays with purified components

• Cellular and Subcellular Localization:

  • Fluorescently tagged SptP variants to track localization in real-time

  • Subcellular fractionation coupled with biochemical assays

  • Proximity labeling techniques to identify proteins in close association with SptP

A true experimental research design approach is recommended, which relies on statistical analysis to prove or disprove specific hypotheses about SptP function . This would include:

• Control groups not subjected to changes

• Experimental groups experiencing manipulated variables

• Random distribution of variables where appropriate

Statistical analysis plans should be developed prior to experimentation to ensure appropriate sample sizes, minimize bias, and account for potential confounding factors .

How should researchers track SptP localization in infected cells using immunofluorescence?

Tracking SptP localization in infected cells requires careful experimental design and optimization of immunofluorescence protocols. The following methodological approach is recommended:

• Generation of Tagged SptP Constructs:

  • Create C-terminally epitope-tagged SptP (e.g., SptP-FLAG) through chromosomal integration to maintain native expression levels

  • Validate that the tag does not interfere with SptP function through complementation assays in ΔsptP mutants

• Infection Protocol:

  • Infect host cells (e.g., HeLa) with tagged Salmonella strains for 1 hour

  • Add gentamicin to kill extracellular bacteria

  • Process cells for immunofluorescence at various time points post-infection (1-8 hours)

• Immunofluorescence Procedure:

  • Fix cells with paraformaldehyde (typically 4%) to preserve protein localization

  • Permeabilize with detergent (0.1-0.2% Triton X-100) to allow antibody access

  • Block with BSA or serum to reduce non-specific binding

  • Incubate with primary antibodies against the epitope tag and markers for:

    • Bacteria (e.g., anti-LPS)

    • SCVs (e.g., anti-LAMP1)

    • Sifs (e.g., anti-LAMP1)

    • Host cellular compartments

  • Apply fluorescently-labeled secondary antibodies with distinct emission spectra

  • Counterstain nuclei with DAPI

• Confocal Microscopy and Analysis:

  • Use confocal microscopy for superior resolution of subcellular structures

  • Acquire z-stacks to capture the full three-dimensional distribution

  • Perform quantitative analysis including:

    • Percentage of bacteria associated with SptP signal

    • Co-localization coefficients with various cellular markers

    • Signal intensity measurements at different time points

When implementing this method, researchers have observed that SptP accumulates around approximately 15% ± 3% of intracellular bacteria and associates with LAMP1-positive SCVs but is excluded from Sif structures .

What cell fractionation techniques are most effective for studying SptP's association with cellular compartments?

Mechanical fractionation provides a powerful approach for analyzing SptP's distribution across cellular compartments during Salmonella infection. Based on published methodologies, the following protocol is recommended:

• Infection and Cell Preparation:

  • Infect host cells with epitope-tagged Salmonella strains

  • At desired time points, wash cells thoroughly to remove non-internalized bacteria

  • Harvest cells by gentle scraping to preserve membrane structures

• Mechanical Fractionation:

  • Lyse cells using mechanical disruption methods (e.g., Dounce homogenization) that preserve organelle integrity

  • Use isotonic buffers supplemented with protease and phosphatase inhibitors

  • Apply differential centrifugation to separate:

    • Pellet fraction containing plasma membranes, nuclei, and internalized bacteria

    • Internal membrane fraction

    • Cytoplasmic fraction

• Fraction Verification:

  • Confirm successful fractionation by immunoblotting for compartment-specific markers:

    • Plasma membranes: caveolin

    • Nuclei: histone

    • Bacteria: AcrB

    • Internal membranes: calnexin

    • Cytoplasm: Hsp90

• SptP Detection and Quantification:

  • Analyze fractions by immunoblotting for SptP-FLAG

  • Quantify relative distribution across fractions

  • Compare with distribution patterns of bacterial and host proteins of interest

This approach has revealed that SptP is predominantly associated with the pellet fraction containing plasma membranes, nuclei, and internalized bacteria, as well as with internal membrane fractions, but is notably absent from the cytoplasmic fraction . This pattern of localization persists throughout infection, from early (1-2 hours) to late (8 hours) time points.

The methodological advantage of fractionation over microscopy is that it provides a biochemical assessment of protein distribution that can detect associations not readily visualized by immunofluorescence due to signal threshold limitations.

How can researchers assess SptP's phosphatase activity against potential substrates?

Evaluating SptP's protein tyrosine phosphatase (PTPase) activity against candidate substrates requires a systematic biochemical approach. The following methodology is recommended:

• Protein Purification:

  • Express recombinant SptP variants in E. coli:

    • Wild-type SptP

    • Catalytically inactive PTPase mutant (e.g., C481S)

    • PTPase domain only

  • Purify using affinity chromatography with appropriate tags (His, GST)

  • Verify purity by SDS-PAGE and protein identity by mass spectrometry

• In Vitro Phosphatase Assays:

  • Prepare candidate substrate proteins in tyrosine-phosphorylated form:

    • Express in eukaryotic systems with active tyrosine kinases

    • Perform in vitro phosphorylation with purified tyrosine kinases

    • Use commercially available phosphorylated peptides derived from candidate substrates

  • Incubate phosphorylated substrates with purified SptP variants

  • Measure phosphatase activity by:

    • Detection of released inorganic phosphate (colorimetric assays)

    • Monitoring substrate dephosphorylation via phospho-specific antibodies

    • Mass spectrometry to identify specific dephosphorylation sites

• Substrate Validation in Cellular Context:

  • Introduce wild-type or catalytically inactive SptP into cells

  • Immunoprecipitate candidate substrates

  • Assess phosphorylation status using phospho-tyrosine antibodies

  • Compare phosphorylation levels in the presence of active versus inactive SptP

• Determination of Enzyme Kinetics:

  • Measure initial reaction rates at varying substrate concentrations

  • Calculate Michaelis-Menten parameters (Km, Vmax, kcat)

  • Compare kinetic parameters across different substrates to determine specificity

This approach has successfully identified VCP as a substrate for SptP's PTPase activity, with SptP demonstrating specific dephosphorylation of VCP that enhances pathogen replication in SCVs .

When conducting these assays, it is essential to include appropriate controls:

• Catalytically inactive SptP mutants to confirm specificity

• Phosphatase inhibitors to validate enzymatic activity

• Multiple candidate substrates to assess selectivity

What statistical analysis plan (SAP) is appropriate for evaluating SptP-mediated effects on bacterial replication?

Developing a robust statistical analysis plan is crucial for obtaining reliable and meaningful results when studying SptP's effects on Salmonella replication. The following approach is recommended:

• Pre-Experimental Planning:

  • Clearly define primary and secondary endpoints (e.g., fold-replication, percentage of Sif-positive cells)

  • Determine appropriate sample sizes through power analysis

  • Establish inclusion/exclusion criteria for cells and bacterial populations

  • Pre-specify analysis methods and significance thresholds

• Experimental Design Considerations:

  • Include multiple bacterial strains:

    • Wild-type Salmonella

    • ΔsptP deletion mutant

    • Complemented strain (ΔsptP + plasmid-encoded SptP)

    • Domain-specific mutants (GAP-deficient, PTPase-deficient)

  • Implement true experimental design elements:

    • Control groups not subjected to changes

    • Experimental groups with manipulated variables

    • Random distribution where appropriate

• Data Collection and Quality Control:

  • Ensure consistent data collection methods across experiments

  • Implement blinding during assessment of microscopy images

  • Establish protocols for handling outliers and missing data

  • Monitor data quality throughout the experimental process

• Statistical Methods:

  • For bacterial replication assays:

    • Use ANOVA with post-hoc tests for comparing multiple strains

    • Apply appropriate transformations (log transformation for fold-change data)

    • Include repeated measures analysis for time-course experiments

  • For immunofluorescence quantification:

    • Use chi-square or Fisher's exact test for categorical outcomes

    • Apply non-parametric tests for non-normally distributed data

  • Adjust for multiple comparisons using Bonferroni or false discovery rate methods

• Reporting and Visualization:

  • Present results with appropriate measures of central tendency and dispersion

  • Include confidence intervals for primary endpoints

  • Create clear visualizations that accurately represent the data

  • Report exact p-values rather than threshold indicators

When implementing this approach, researchers have observed significant differences in intracellular replication: wild-type Salmonella demonstrated 14.3- ± 1.4-fold replication, the ΔsptP mutant showed only 4.2- ± 2.6-fold replication, and the complemented strain achieved 35.2- ± 2.8-fold replication at 8 hours post-infection .

A well-constructed SAP ensures that the collected data will be appropriately and relevant to answering the research questions, minimizing biases and confounding factors through careful selection of sample size, avoiding selection bias, and implementing randomization techniques .

How can SptP be exploited for vaccine development against intracellular pathogens?

SptP's ability to deliver heterologous antigens into the host cell cytoplasm makes it a promising candidate for vaccine development against intracellular pathogens. The methodological approach would include:

• Fusion Protein Engineering:

  • Design chimeric constructs fusing protective antigens from target pathogens to SptP

  • Determine optimal fusion configurations (N-terminal, C-terminal, or internal)

  • Preserve critical functional domains required for T3SS-mediated delivery

  • Incorporate appropriate linkers to minimize structural interference

• Vector Development:

  • Utilize Recombinant Attenuated Salmonella Vaccine (RASV) strains

  • Optimize expression systems (promoters, ribosome binding sites)

  • Balance immunogenicity with attenuation to ensure safety

• Immune Response Evaluation:

  • Assess antigen-specific CD8+ T-cell responses through:

    • Intracellular cytokine staining

    • Tetramer analysis

    • ELISpot assays

  • Evaluate functional aspects:

    • Cytotoxicity assays

    • Proliferation assays

    • Memory phenotyping

• Protection Studies:

  • Challenge immunized animals with target pathogens

  • Monitor protection parameters:

    • Pathogen load

    • Clinical symptoms

    • Survival rates

This approach has shown promising results in experimental systems. For instance, when a protective MHC class I epitope from lymphocytic choriomeningitis virus was fused to SptP and delivered via Salmonella, it induced strong and persistent virus-specific cytotoxic T-lymphocyte responses in mice that provided protection against viral challenge .

While encouraging, the approach requires careful consideration of potential limitations:

• Not all antigens may fold correctly when fused to SptP

• The immune response may target the SptP carrier in addition to the desired antigen

• Pre-existing immunity to Salmonella could reduce vaccine efficacy in some populations

What are the current technical challenges in purifying recombinant SptP for in vitro studies?

Purification of functional recombinant SptP presents several technical challenges that researchers must address to obtain high-quality protein for in vitro studies:

• Solubility Issues:

  • SptP often forms inclusion bodies when overexpressed in E. coli

  • Methodological solutions include:

    • Lower induction temperatures (16-25°C)

    • Reduced IPTG concentrations

    • Co-expression with chaperones

    • Fusion to solubility-enhancing tags (MBP, SUMO)

• Maintaining Dual Domain Functionality:

  • Both GAP and PTPase domains must retain catalytic activity

  • This requires:

    • Proper folding of both domains

    • Appropriate buffer conditions during purification

    • Verification of activity for each domain separately

• Stability Concerns:

  • Full-length SptP may undergo degradation during purification

  • Strategies to address this include:

    • Addition of protease inhibitors throughout purification

    • Optimization of buffer components (reducing agents, pH)

    • Storage in glycerol at -80°C to preserve activity

• Purification Protocol Optimization:

  • Two-step or multi-step purification is typically required:

    • Initial capture via affinity chromatography (His-tag, GST)

    • Secondary purification via ion exchange or size exclusion

    • Final polishing step if necessary

• Quality Control Assessments:

  • Critical quality checks include:

    • SDS-PAGE for purity analysis

    • Western blotting for identity confirmation

    • Mass spectrometry for intactness verification

    • Circular dichroism for secondary structure analysis

    • Functional assays for both GAP and PTPase activities

Successful purification of catalytically active SptP is essential for biochemical characterization of its interactions with host substrates such as VCP . Researchers must carefully optimize expression and purification conditions to maintain the structural integrity and dual functionality of this complex bacterial effector protein.

How can systems biology approaches enhance our understanding of SptP's role in Salmonella pathogenesis?

Systems biology offers powerful frameworks for comprehensively understanding SptP's multifaceted roles in Salmonella pathogenesis. The following methodological approaches are recommended:

• Multi-omics Integration:

  • Comparative proteomics:

    • Quantify host proteome changes in response to wild-type versus ΔsptP Salmonella

    • Identify differentially regulated pathways

  • Phosphoproteomics:

    • Map tyrosine phosphorylation changes dependent on SptP's PTPase activity

    • Identify network-level impacts beyond direct substrates

  • Transcriptomics:

    • Assess host transcriptional responses to various SptP mutants

    • Identify regulatory networks affected by SptP activity

• Network Analysis:

  • Construct protein-protein interaction networks centered on SptP

  • Identify hub proteins and regulatory nodes affected by SptP

  • Apply pathway enrichment analysis to identify biological processes impacted

• Temporal Dynamics Modeling:

  • Develop mathematical models of SptP activity over time

  • Incorporate differential equations to describe:

    • Cytoskeletal dynamics during entry

    • SCV maturation processes

    • Intracellular replication kinetics

  • Validate models with experimental time-course data

• Spatial Systems Biology:

  • Apply advanced imaging techniques (super-resolution microscopy, live-cell imaging)

  • Develop agent-based models of SptP localization and activity

  • Create spatiotemporal maps of SptP-dependent modifications

• Integrative Data Analysis:

  • Implement machine learning approaches to identify patterns across datasets

  • Develop predictive models of SptP-dependent outcomes

  • Generate testable hypotheses for experimental validation

This systems-level approach would complement traditional reductionist methods by revealing emergent properties and network-level effects of SptP activity. For example, while we know that SptP dephosphorylates VCP to enhance pathogen replication , a systems approach might reveal how this single dephosphorylation event triggers cascading effects across multiple cellular pathways.

The statistical analysis plan for such complex datasets should be developed before experimentation begins, ensuring appropriate sample sizes, minimizing biases, and accounting for potential confounding factors across multiple data types .